Cite
Immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study
MLA
Marine Jary, et al. “Immune Microenvironment in Patients with Mismatch‐repair‐proficient Oligometastatic Colorectal Cancer Exposed to Chemotherapy: The Randomized MIROX GERCOR Cohort Study.” Molecular Oncology, vol. 16, no. 11, June 2022, pp. 2260–73. EBSCOhost, https://doi.org/10.1002/1878-0261.13173.
APA
Marine Jary, Wen‐Wei Liu, Dongyao Yan, Isaac Bai, Andrea Muranyi, Elise Colle, Isabelle Brocheriou, Anthony Turpin, Nina Radosevic‐Robin, Pierre Bourgoin, Frédérique Penault‐Llorca, Romain Cohen, Dewi Vernerey, Thierry André, Christophe Borg, Kandavel Shanmugam, & Magali Svrcek. (2022). Immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study. Molecular Oncology, 16(11), 2260–2273. https://doi.org/10.1002/1878-0261.13173
Chicago
Marine Jary, Wen‐Wei Liu, Dongyao Yan, Isaac Bai, Andrea Muranyi, Elise Colle, Isabelle Brocheriou, et al. 2022. “Immune Microenvironment in Patients with Mismatch‐repair‐proficient Oligometastatic Colorectal Cancer Exposed to Chemotherapy: The Randomized MIROX GERCOR Cohort Study.” Molecular Oncology 16 (11): 2260–73. doi:10.1002/1878-0261.13173.